Research progress and application of the CRISPR/Cas9 gene-editing technology based on hepatocellular carcinoma

• Main Authors: Shijing Yu (Author), Ruirui Zhao (Author), Bingchen Zhang (Author), Chunmei Lai (Author), Linyan Li (Author), Jiangwen Shen (Author), Xiarong Tan (Author), Jingwei Shao (Author)
• Format: Book
• Published: Elsevier, 2023-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Hepatocellular carcinoma (HCC) is now a common cause of cancer death, with no obvious change in patient survival over the past few years. Although the traditional therapeutic modalities for HCC patients mainly involved in surgery, chemotherapy, and radiotherapy, which have achieved admirable achieve...